Sandler Alan B. Insider Trades & Stock Holdings

Chief Development Officer · Revolution Medicines, Inc. · Latest filing Sep 29, 2026

Sandler Alan B., Chief Development Officer at Revolution Medicines, Inc. has 2 Form 4 trades on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($1.34M), net -$1.34M. Latest filing: disposed of 6.31K shares of $RVMD on Sep 29, 2026 at $202.14.

Trades on file

2

Open-market bought

$0

Open-market sold

$1.34M

Net open-market

-$1.34M

Latest filing

Sep 29, 2026

All insider trades by Sandler Alan B.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 29, 2026	$RVMD	Sell (Open-market sale) 10b5-1	6.31K	$202.14	$1.28M			-2.3%			Chief Development Officer		—
Sep 16, 2026	$RVMD	Sell (Open-market sale) 10b5-1	341	$199.24	$67.94K			-2.6%	-9.2%		Chief Development Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Sandler Alan B. traded

• $RVMD

Frequently asked questions

Has Sandler Alan B. been buying or selling stock?

Sandler Alan B. has 0 open-market purchases and 2 open-market sales on file, net -$1.34M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Sandler Alan B.'s latest insider trade?

disposed of 6.31K shares of $RVMD on Sep 29, 2026 at $202.14.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.